DK0707472T3 - Fremgangsmåde til regulering af størrelsen af liposomer - Google Patents

Fremgangsmåde til regulering af størrelsen af liposomer

Info

Publication number
DK0707472T3
DK0707472T3 DK94921494T DK94921494T DK0707472T3 DK 0707472 T3 DK0707472 T3 DK 0707472T3 DK 94921494 T DK94921494 T DK 94921494T DK 94921494 T DK94921494 T DK 94921494T DK 0707472 T3 DK0707472 T3 DK 0707472T3
Authority
DK
Denmark
Prior art keywords
liposomes
regulating
size
particle size
mean particle
Prior art date
Application number
DK94921494T
Other languages
English (en)
Inventor
Laura M Edgerly-Pflug
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of DK0707472T3 publication Critical patent/DK0707472T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK94921494T 1993-07-08 1994-07-08 Fremgangsmåde til regulering af størrelsen af liposomer DK0707472T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8874293A 1993-07-08 1993-07-08
PCT/US1994/007683 WO1995001777A1 (en) 1993-07-08 1994-07-08 Method of controlling the size of liposomes

Publications (1)

Publication Number Publication Date
DK0707472T3 true DK0707472T3 (da) 2001-04-17

Family

ID=22213183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94921494T DK0707472T3 (da) 1993-07-08 1994-07-08 Fremgangsmåde til regulering af størrelsen af liposomer

Country Status (11)

Country Link
US (1) US6596305B1 (da)
EP (1) EP0707472B1 (da)
JP (1) JP3479535B2 (da)
AT (1) ATE199640T1 (da)
CA (1) CA2166465C (da)
DE (1) DE69426884T2 (da)
DK (1) DK0707472T3 (da)
ES (1) ES2154680T3 (da)
GR (1) GR3035825T3 (da)
PT (1) PT707472E (da)
WO (1) WO1995001777A1 (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001333A (en) * 1997-09-12 1999-12-14 See; Jackie R. Methods of preparing micro encapsulated agents for use in the detection of tumors by CT imaging
KR20010101837A (ko) * 1999-02-08 2001-11-14 스톤 스티븐 에프. 리포좀 크기 조절 방법
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
PL371626A1 (en) * 2002-01-21 2005-06-27 Vasogen Ireland Limited Pharmaceutically acceptable phosphate-glycerol carrying bodies
US20030224039A1 (en) * 2002-03-05 2003-12-04 Transave, Inc. Methods for entrapment of bioactive agent in a liposome or lipid complex
WO2004002453A1 (en) 2002-06-28 2004-01-08 Protiva Biotherapeutics Ltd. Method and apparatus for producing liposomes
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US9198645B2 (en) * 2003-11-26 2015-12-01 The United States of America, as represented by the Secretary of Commerce of The National Institute of Standards and Technology Controlled vesicle self-assembly in continuous two phase flow microfluidic channels
US20050129750A1 (en) * 2003-12-15 2005-06-16 Yu-Fang Hu Process for producing liposome suspension and product containing liposome suspension produced thereby
US8784881B2 (en) * 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
US8715591B2 (en) * 2004-07-21 2014-05-06 The United States of America, as represented by the Secretary of Commerce, The National Institute of Standards and Technology Microfluidic apparatus to control liposome formation
AU2006274413B2 (en) * 2005-07-27 2013-01-10 Arbutus Biopharma Corporation Systems and methods for manufacturing liposomes
US8226975B2 (en) 2005-12-08 2012-07-24 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
BRPI0619565A2 (pt) * 2005-12-08 2011-10-04 Wyeth Corp composições lipossÈmicas
WO2007117550A2 (en) * 2006-04-06 2007-10-18 Transave, Inc. Methods for coacervation induced liposomal encapsulation and formulations thereof
US20080268031A1 (en) * 2007-03-15 2008-10-30 Benjamin Johnson Therapeutic Treatment of Dermatologic Skin Disorders
WO2008114274A1 (en) * 2007-03-19 2008-09-25 Fresenius Kabi Onclology Ltd. Proliposomal and liposomal compositions
WO2008137717A1 (en) 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
WO2009091531A2 (en) * 2008-01-16 2009-07-23 The General Hospital Corporation Uniform-sized, multi-drug carrying and photosensitive liposomes for advance drug delivery
US20090246234A1 (en) * 2008-04-01 2009-10-01 Benjamin Johnson Therapeutic Treatment Using Niacin for Skin Disorders
US20100081954A1 (en) * 2008-09-30 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method, device, and system to control pH in pulmonary tissue of a subject
WO2010135714A2 (en) 2009-05-22 2010-11-25 The Methodist Hospital Research Institute Methods for modulating adipocyte expression using microrna compositions
TWI410256B (zh) * 2010-01-07 2013-10-01 Nat Univ Tsing Hua 雙重乳化法製備微脂體之新型裝置
US10016389B2 (en) * 2011-01-05 2018-07-10 Livon Laboratories Method of making liposomes, liposome compositions made by the methods, and methods of using the same
US8642655B2 (en) 2011-03-09 2014-02-04 Benjamin Johnson Systems and methods for preventing cancer and treating skin lesions
GB201116248D0 (en) * 2011-09-20 2011-11-02 Glaxosmithkline Biolog Sa Liposome production using isopropanol
CA2871820C (en) * 2012-05-10 2020-11-03 Painreform Ltd. Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
JP6402097B2 (ja) 2012-05-21 2018-10-10 インスメッド インコーポレイテッド 肺感染症を処置するためのシステム
US20140120157A1 (en) 2012-09-19 2014-05-01 Georgetown University Targeted liposomes
ES2743039T3 (es) 2012-11-29 2020-02-18 Insmed Inc Formulaciones de vancomicina estabilizada
SI3142643T1 (sl) 2014-05-15 2019-11-29 Insmed Inc Postopki za zdravljenje pljučnih netuberkuloznih mikobakterijskih infekcij
CN106568831B (zh) * 2016-11-18 2019-07-23 武汉理工大学 一种用于检测磷酸肌醇的多孔膜材料及其制备与检测方法
WO2019005830A1 (en) * 2017-06-26 2019-01-03 Fordoz Pharma Corp. NANOSOME FORMULATIONS OF APREPITANT AND METHODS AND APPLICATIONS THEREOF
GB2610090B (en) * 2017-08-01 2023-05-17 Ankasa Regenerative Therapeutics Inc WNT compositions and methods of process from serum-free culturing conditions
EP3705179B1 (en) * 2017-11-01 2024-05-22 Osaka University Method and system for producing lipid particles having desired particle diameter
US11344497B1 (en) 2017-12-08 2022-05-31 Quicksilver Scientific, Inc. Mitochondrial performance enhancement nanoemulsion
US10722465B1 (en) 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
US11571386B2 (en) 2018-03-30 2023-02-07 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
US11291702B1 (en) 2019-04-15 2022-04-05 Quicksilver Scientific, Inc. Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039285A (en) * 1975-10-10 1977-08-02 Ortho Diagnostics, Inc. Single sample method for determination of lipoprotein concentrations in blood
US4184849A (en) * 1977-12-05 1980-01-22 Technicon Instruments Corporation Mixed agglutination
US4529561A (en) 1978-03-24 1985-07-16 The Regents Of The University Of California Method for producing liposomes in selected size range
US4522803A (en) 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4588578A (en) 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
CA1237670A (en) 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
EP0158441B2 (en) * 1984-03-08 2001-04-04 Phares Pharmaceutical Research N.V. Liposome-forming composition
US4721612A (en) 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes
US4619895A (en) * 1984-05-10 1986-10-28 The Regents Of The University Of California Lipoprotein marker for hypertriglyceridemia
US5008050A (en) 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
US5077056A (en) 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
GB8426264D0 (en) 1984-10-17 1984-11-21 Alcan Int Ltd Porous films
US4861580A (en) 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US4737323A (en) 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
US5154930A (en) 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US5082664A (en) 1987-05-22 1992-01-21 The Liposome Company, Inc. Prostaglandin-lipid formulations
WO1989000846A1 (en) 1987-07-29 1989-02-09 The Liposome Company, Inc. Method for size separation of particles
US4994213A (en) * 1988-05-17 1991-02-19 Liposome Technology, Inc. Method of preparing lipid structures
US5000887A (en) * 1988-05-17 1991-03-19 Liposome Technology, Inc. Preparation of uniform-size liposomes
WO1989011335A1 (en) 1988-05-17 1989-11-30 Liposome Technology, Inc. Preparation of uniform-size liposomes and other lipid structures
US4927637A (en) 1989-01-17 1990-05-22 Liposome Technology, Inc. Liposome extrusion method
DE69026820T2 (de) 1989-03-31 1996-11-28 Univ California Zubereitung von liposomen- und lipid-komplexzusammensetzungen

Also Published As

Publication number Publication date
ES2154680T3 (es) 2001-04-16
US6596305B1 (en) 2003-07-22
JPH08512240A (ja) 1996-12-24
CA2166465C (en) 2003-10-14
DE69426884T2 (de) 2001-06-21
WO1995001777A1 (en) 1995-01-19
PT707472E (pt) 2001-07-31
GR3035825T3 (en) 2001-07-31
EP0707472B1 (en) 2001-03-14
ATE199640T1 (de) 2001-03-15
CA2166465A1 (en) 1995-01-19
JP3479535B2 (ja) 2003-12-15
EP0707472A1 (en) 1996-04-24
DE69426884D1 (de) 2001-04-19

Similar Documents

Publication Publication Date Title
DK0707472T3 (da) Fremgangsmåde til regulering af størrelsen af liposomer
DE69130912D1 (de) Antikörperherstellung
ATE194614T1 (de) Verfahren zur herstellung von 3- arylbenzofuranonen
ATE199709T1 (de) Verfahren zur herstellung von (+)compactin und (+)mevinolin derivaten mit beta-hydroxy-delta- lactonresten
ATA109993A (de) Verfahren zur herstellung von neuen polypropylenendurch chemische degradierung
SE9604253D0 (sv) New manufacturing process metoprolol
DK0503453T3 (da) Fremgangsmåde til fremstilling af cephalosporiner og mellemprodukter i denne fremgangsmåde
NO961947L (no) Faseseparasjonsapparatur
ES2182622A1 (es) Compuestos a base de compuestos de polialquil-1-oxa-diazaespirodecanos.
DK56893D0 (da) Fremgangsmaade til fremstilling af et fjederindlaeg
DK0619305T3 (da) Lactonforbindelse og fremgangsmåde til fremstilling deraf
ATE144979T1 (de) Verfahren zur herstellung von 3,5,6- trichloropyridin-2-ol
DE59301293D1 (de) Verfahren zur Herstellung von Vinylglykolen, durch Isomerisierung
MY116842A (en) Manufacturing process for felopipine
EA199800468A1 (ru) 25-гидрокси-16-ен-26,27-бисгомохолекальциферолы
ATE175967T1 (de) Verfahren zur herstellung von 2-amino-6- halogenopurin und synthese einer zwischenverbindung
NO306067B1 (no) Polymeriserbar harpiks, fremgangsmåte for fremstilling derav samt harpiksbeleggsystem
ATE156819T1 (de) Verfahren zur herstellung einer oxazolidincarbon säure nützlich für die herstellung von therapeutischen taxoiden
ATA221292A (de) Neues verfahren zur herstellung von 3-vinylcephalosporinverbindungen
ATE150438T1 (de) Verfahren zur herstellung von 1,1,1,2- tetrafluorethan
DK0427197T3 (da) Fremgangsmåde til fremstilling af vinyl-GABA
ATE200776T1 (de) Verfahren zur herstellung von 2,4,5-tribrompyrrol-3-carbonitril
EA199800216A1 (ru) Полиизоцианатные частицы регулируемого размера и распределения частиц по размеру
DK0704438T3 (da) Fremgangsmåde til fremstilling af 2-cyaniminothiazolidin
WO1990000314A3 (en) Method of activation of superconductors and devices produced thereby